Skip to content

    TransMedics Group (TMDX) stock price & financials

    View TMDX earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance24.7% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $108.76M
    $121.62M
    $143.54M
    $157.37M
    $143.82M
    +32.2%
    $160.76M
    +32.2%
    $173.93M
    +21.2%
    $189.95M
    +20.7%
    Strengthening
    Operating Profit
    $3.92M
    $8.64M
    $27.44M
    $36.57M
    $23.30M
    +493.9%
    $21.27M
    +146.1%
    $13.30M
    -51.5%
    $23.74M
    -35.1%
    Strengthening
    Net Profit
    $4.22M
    $6.86M
    $25.68M
    $34.91M
    $24.32M
    +476.8%
    $105.38M
    +1436.9%
    $7.32M
    -71.5%
    $14.68M
    -57.9%
    Strengthening
    EPS
    $0.13
    $0.76
    $1.03
    $0.71
    +446.2%
    $0.21
    -72.4%
    $0.42
    -59.2%
    Weakening
    Other Income
    $322.0K
    -$1.66M
    -$767.0K
    -$385.0K
    -$269.0K
    -183.5%
    $360.0K
    -$4.81M
    -527.4%
    -$4.33M
    -1024.9%
    Weakening
    Interest
    $3.62M
    $3.57M
    $3.46M
    $3.48M
    $3.49M
    -3.5%
    $3.35M
    -6.1%
    $7.17M
    +107.2%
    $7.22M
    +107.9%
    Strengthening
    Depreciation
    Profit before Tax
    $4.25M
    $6.99M
    $26.68M
    $36.18M
    $23.03M
    +442.5%
    $21.63M
    +209.5%
    $8.48M
    -68.2%
    $19.41M
    -46.4%
    Strengthening
    MarginsOPM
    3.6%
    7.1%
    19.1%
    23.2%
    16.2%
    +348.8%
    13.2%
    +86.1%
    7.6%
    -60.0%
    12.5%
    -46.2%
    Weakening
    Tax
    0.7%
    1.9%
    3.7%
    3.5%
    -5.6%
    -922.1%
    -387.1%
    -20583.6%
    13.8%
    +269.7%
    24.3%
    +591.5%
    Weakening
    ReturnsROIC
    0.8%
    1.3%
    5.0%
    6.7%
    4.7%
    +476.8%
    20.3%
    +1436.9%
    1.4%
    -71.5%
    2.8%
    -57.9%
    Strengthening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$20.24M$20.09M$24.58M$25.58M$201.18M$394.81M$336.65M$488.37M$472.68M
    Short-Term Investments$60.60M$101.06M$66.87M
    Total Current Assets$34.79M$100.00M$146.77M$118.70M$252.29M$510.65M$497.22M$637.78M$651.12M
    Net PP&E$3.47M$4.79M$4.75M$15.69M$24.35M$180.49M$292.45M$332.81M$369.95M
    Goodwill$11.99M$11.55M$11.55M$11.55M
    Intangibles$2.35M$2.15M$1.95M$0
    Total Assets$42.16M$105.30M$152.03M$134.89M$277.15M$706.05M$804.08M$1.07B$1.46B
    LiabilitiesTotal Current Liabilities$12.55M$16.11M$11.88M$23.24M$23.66M$54.93M$59.91M$89.31M$98.28M
    Short-Term Debt$10.00M$20.00M
    Long-Term Debt$33.67M$34.15M$34.66M$35.20M$58.70M
    Long-Term Leases$8.60M$7.42M$7.71M$6.25M$3.58M$2.41M
    Total Liabilities$47.88M$50.65M$48.13M$67.04M$89.77M$568.85M$575.47M$595.27M$946.34M
    EquityCommon Stock & APIC$1.0K$424.13M$502.22M$510.49M$666.28M$641.11M$697.21M$750.93M$774.22M
    Retained Earnings-$335.94M-$369.48M-$398.23M-$442.45M-$478.68M-$503.70M-$468.24M-$277.95M-$255.95M
    Total Equity-$192.24M$54.65M$103.89M$67.85M$187.38M$137.20M$228.60M$473.10M$518.05M
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$25.98M-$32.29M-$30.27M-$28.86M-$45.82M-$13.03M$48.80M$192.84M$145.93M
    Cash from Investing$12.31M-$60.50M-$41.60M$29.27M$54.51M-$193.95M-$129.30M-$59.25M-$66.89M
    Cash from Financing$22.06M$92.72M$75.55M$1.39M$167.93M$400.42M$22.87M$16.86M$11.47M
    SummaryCapital Expenditure-$418.0K-$165.0K-$455.0K-$3.52M-$11.91M-$151.85M-$129.74M-$59.25M-$66.89M
    Free Cash Flow-$26.40M-$32.45M-$30.72M-$32.38M-$57.72M-$164.88M-$80.94M$133.59M$79.04M
    FCF Margin-202.8%-137.5%-119.8%-107.0%-61.8%-68.2%-18.3%22.1%11.8%

    Ratios